Drug Discovery
PPI inhibitors to fight cancer are making progress in clinical trials
Small molecule PPI inhibitors are on the brink of improving cancer treatments
Bio
Kavita Iyer graduated with a Bachelor of Pharmacy from the University of Mumbai in 2011. Subsequently she earned her PhD in Medicinal Chemistry from Virginia Commonwealth University, USA. She further pursued a post-doctoral fellowship in the Department of Physiology and Biophysics at VCU where she was trained as a structural biologist and subsequently worked as a Research Scientist. Prior to joining CAS, she worked briefly at ACSII.
Emerging Science
Co-occurring concepts reveal new research directions in immuno-oncology
Concept co-occurrence analysis shows the newest ideas in scientific discovery and drives innovation in immuno-oncology.
Drug Discovery
PROTACs are revolutionizing small molecule drug development
PROTACs are driving small molecule drug development to treat cancer, neurodegenerative diseases and more
Biotechnology
Webinar: Big data insights in the quest to cure cancer
Experts discuss emerging trends in immuno-oncology, data challenges, and opportunities ahead for cancer researchers.
Drug Discovery
Emerging trends in immunotherapy and cancer
Immuno-oncology has the potential to treat cancer without sacrificing the patient's wellbeing.